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Abstract
For genome-wide association studies in family-based designs, we propose a new, universally applicable approach. The new
test statistic exploits all available information about the association, while, by virtue of its design, it maintains the same
robustness against population admixture as traditional family-based approaches that are based exclusively on the within-
family information. The approach is suitable for the analysis of almost any trait type, e.g. binary, continuous, time-to-onset,
multivariate, etc., and combinations of those. We use simulation studies to verify all theoretically derived properties of the
approach, estimate its power, and compare it with other standard approaches. We illustrate the practical implications of the
new analysis method by an application to a lung-function phenotype, forced expiratory volume in one second (FEV1) in 4
genome-wide association studies.
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Introduction
During the analysis phase of genome-wide association studies,
one is confronted with numerous statistical challenges. One of
them is the decision about the ‘‘right’’ balance between
maximization of the statistical power and, at the same time,
robustness against confounding. In family-based designs, the
possible range of analysis options spans from a traditional
family-based association analysis [1–4], e.g. TDT, PDT, FBAT,
to the application of population-based analysis methods that have
been adapted to family-data [1–3]. While, by definition, the first
group of approaches is completely immune to population
admixture and model misspecification of the phenotype, and can
be applied to any phenotype that is permissible in the family-based
association testing framework (FBAT [4–6]), the second category
of approaches maximizes the statistical power by a population-
based analysis. The phenotypes are modeled as a function of the
genotype, and population-based methods such as genomic control
[7,8], STRUCTURE [9] and EIGENSTRAT [10], are applied to
account for the effects of population admixture and stratification.
Hybrid-approaches that combine elements of both population-
based and family-based analysis methods, e.g. VanSteen algorithm
[11] and Ionita weighting-schemes [12,13] have been suggested to
bridge between the 2 types of analysis strategies. Contrary to the
other methods that combine family data and unrelated samples
[14–17], such hybrid testing strategies maintain the 2 key features
of the family-based association tests: The robustness against
confounding due to population admixture and heterogeneity, and
the analysis flexibility of the approach with respect to the choice of
the target phenotype. Such 2-stage testing strategies utilize the
information about the association at a population-level, the
between-family component, to prioritize SNPs for the second step
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with a family-based test. The hybrid approaches can achieve
power levels that are similar to approaches in which standard
population-based methods are applied to family-data, but the
optimal combination of the 2 sources of information (the between-
family component and the within-family component) is not
straightforward in the hybrid approaches.
In this communication, we propose a new family-based
association test for genome-wide association studies that combines
all sources of information about association, the between and the
within-family information, into one single test statistic. The new
test is robust against population-admixture even though both
components, the between and the within-family components, are
used to assess the evidence for association. The approach is
applicable to all phenotypes or combinations of phenotypes that
can be handled in the FBAT-approach, e.g. binary, continuous,
time-to-onset, multivariate, etc [4–6,18]. While the correct model
specification for the phenotypes will increase the power of the
proposed test statistic, misspecification of the phenotypic model
does not affect the validity of the approach. Using extensive
simulation studies, we verify the theoretically derived properties of
the test statistic, assess its power and compare it with other
standard approaches. An application to the Framing heart study
(FHS) illustrates the value of the approach in practice. A new
genetic locus for the lung-function phenotype, FEV1 (forced
expiratory volume in the first second) is discovered and replicated
in 3 independent, genome-wide association studies.
Methods
We assume that in a family-based association study, n family
members have been genotyped at m loci with a genome-wide SNP-
chip. For each marker locus, a family-based association test is
constructed based on the offspring phenotype and the within-
family information. The within-family information is defined as
the difference between the observed, genetic marker score and the
expected, genetic marker score, which is computed conditional
upon both the parental genotypes/sufficient statistic [19] under
the assumption of Mendelian transmissions. We denote the family-
based association test for the ith marker locus by FBATi. Such an
FBAT statistic can be the standard TDT, an FBAT for
quantitative/qualitative traits, FBAT-GEE for multivariate traits,
etc [4,6,18,20,21]. Similarly, for the ith marker, the between-
family information can be used to assess the evidence for
association at a population-based level by computing a VanS-
teen-type [11] ‘‘screening statistic’’ Ti. The screening statistic is
computed based on the data for offspring phenotype and the
parental genotypes/sufficient statistic. The statistic Ti can be a
Wald test for the genetic effect size that is estimated based on the
conditional mean model [22], or the estimated power of the
family-based test FBATi [23], either of which is feasible. However,
while the FBATi statistic is robust against population stratification,
the screening statistic Ti is susceptible to confounding. For this
reason, the VanSteen-type testing strategies have restrictively used
the between-family information as weights for p-values of the
FBAT-statistic, but never as a component in the test statistic itself.
Construction of an overall family-based association test
including the population-based and family-based
components
In order to construct a family-based association test that
incorporates both the within and the between-family information,
the Z-statistics that correspond to the p-values of FBATi and Ti are
computed. The statistic Za
* is the a quantile of standard normal
distribution. pFBATi and pTi are the p-value of the FBAT-statistics
and one sided p-value of the screening statistic where the direction
of the one sided screening statistic is defined by the directionality
of FBATi. Based on the statistical independence of FBATi and Ti
[11] under the null-hypothesis, we can obtain an overall family-
based association test statistic Zi by combining both Z-statistics in a
weighted sum,
Zi~wFBATZpFBATi
zwTZpTi

where the parameters wFBAT and wT are standardized weights so
that the overall family-based association test Zi has a normal
distribution with mean 0 and variance 1, i.e. wFBAT
2+wT
2=1.In
the literature, this approach of combining two test statistics is
known as the Liptak-method [24]. However, the Liptak-method
varies here from its standard application in that the 2 test statistics
have to be combined so that confounding in the screening statistic
Ti cannot affect the validity of the overall family-based association
test statistic Zi. In the context of a genome-wide association study
(GWAS), we are able to achieve this goal by using rank-based p-
values for the screening statistic Ti instead of their asymptotic
p-values.
The ‘‘screening statistics’’ Ti are sorted based on their evidence
for association so that T(m) denotes the screening statistic with the
least amount of evidence for association and T(1) the screening
statistic with the largest amount of evidence for association. The
rank-based p-value, (i – 0.5)/m, is then assigned to the ordered
screening test statistics T(i). If there is a tie, then the average of the
ranks will be used for the computation of the rank-based p-value
for the ith marker. Since the null-hypothesis will be true for the
vast majority of the SNPs in a GWAS, the rank-based p-values
provide an alternative way to assess the significance of the
population-based screening statistic Ti. The overall association test
Zi is then computed based on the Z-score for the asymptotic p-
value of the FBAT-statistic and the Z-score for the ranked-based p-
value of the screening statistic Ti. In Text S1 we show that the
overall association test Zi maintains the global significance level a,
under any situations including population admixture and
Author Summary
In genome-wide association studies, the multiple testing
problem and confounding due to population stratification
have been intractable issues. Family-based designs have
considered only the transmission of genotypes from
founder to nonfounder to prevent sensitivity to the
population stratification, which leads to the loss of
information. Here we propose a novel analysis approach
that combines mutually independent FBAT and screening
statistics in a robust way. The proposed method is more
powerful than any other, while it preserves the complete
robustness of family-based association tests, which only
achieves much smaller power level. Furthermore, the
proposed method is virtually as powerful as population-
based approaches/designs, even in the absence of
population stratification. By nature of the proposed
method, it is always robust as long as FBAT is valid, and
the proposed method achieves the optimal efficiency if
our linear model for screening test reasonably explains the
observed data in terms of covariance structure and
population admixture. We illustrate the practical relevance
of the approach by an application in 4 genome-wide
association studies.
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smallest rank-based p-value is 0.5/m. Using the Bonferroni-
correction to adjust for multiple testing, the individual, adjusted
significance level is a/m which will always be smaller than the
smallest rank-based p-value, 0.5/m, unless the pre-specified global
significance level a is great than 0.5. This implies that the overall
family-based association test can never achieve genome-wide
significance just based on the rank-based p-values alone. The
FBAT-statistic has to contribute evidence for the association as
well in order for the overall family-based association test to reach
genome-wide significance. Finally, we have to address the
specification of the weights wFBAT and wT in the overall family-
based association test statistic Zi. While any combination of
weights wFBAT and wT will provide a valid test statistic Zi, the most
powerful overall statistic Zi is approximately achieved when the
ratio of the weights is equal to the ratio of the standardized effect
sizes, the expected effect size of the regression coefficient divided
by its (estimated) standard deviation. For quantitative traits in
unascertained samples, one can show that optimal power levels are
achieved for equal weights, i.e. wFBAT=wT. In general, the equal
weighting scheme seems to provide good power levels for any
disease mode of inheritance and for different trait types, e.g. binary
traits, time-to-onset, etc. The theoretical derivation of optimal
weighting schemes for such scenarios is ongoing research and will
be published subsequently.
Furthermore, it is important to note that, instead of the Liptak-
method, Fisher’s method for combining p-values could have been
used as well to construct an overall family-based association test
which would have the same robustness properties as the overall-
test based on the Liptak-method. However, simulation studies
(data not shown) suggest that the highest power levels are
consistently achieved with the Liptak method. We therefore omit
the approach based on Fisher’s method here.
Results
Type I error for 500K GWAS
In the first part of the simulation study, the type-1 error of the
proposed family-based association test denoted as LIP was assessed
in the absence and in the presence of population admixture, and
we use the Wald test based on the conditional mean model [22]
with between-family component for pTi in our all simulations. For
various scenarios, we verified that the proposed overall family-
based association test maintains the a-level.
For simplicity, we assume in the simulation studies that the
random samples are given, i.e. no ascertainment, and that the
parental genotypes are known. Assuming Hardy-Weinberg
equilibrium, the parental genotypes are generated by drawing
from Bernoulli distributions defined by the allele frequencies. The
offspring genotypes are obtained by simulated Mendelian
transmissions from the parents to the offspring. For the jth trio,
the offspring phenotype Yj is simulated from a Normal distribution
with mean aXj and variance 1, i.e. N(aXj, 1), where the parameter a
represents the genetic effect size and the variable Xj denotes the
offspring genotype. Under the null-hypothesis of no association,
the genetic effect size parameter a will be set to 0.
For scenarios in which population admixture is present, we
assume that the admixture is created by the presence of 2
subpopulations whose phenotypic means differ by 0.2. The allele
frequencies for each marker in the two subpopulations are
generated by the Balding-Nichols model [25]. That is, for each
marker, the allele frequency in an ancestral population is
generated from a uniform distribution between 0.1 and 0.9,
U(0.1, 0.9). Then, the marker allele frequencies for the two
subpopulations are independently sampled from the beta distri-
butions (p(12FST)/FST,( 1 2p)(12FST)/FST) for the whole markers
in each replicate of the simulated GWAS. A survey reported FST
estimates with a median of 0.008 and 90th percentile of 0.028
among Europeans, and the corresponding values are 0.027 and
0.14 among Africans, and 0.043 and 0.12 among Asians [26]. The
value for Wright’s FST was assumed to be 0.05, 0.1, 0.2, or 0.3.
Each trio was assigned to the one of the 2 subpopulations with
50% probability.
In the absence and presence of the population stratification
(FST=0.05, 0.1, 0.2, and 0.3), Table 1 shows the empirical type-1
error rates of the overall association test statistic Zi for a GWAS
with 500,000 SNPs. The estimates for the empirical significance
levels in Table 1 are based on 2,000 replicates. The empirical
genome-wide significance level is calculated as the proportion of
replicates for which the minimum p-values among the 500,000
markers is less than 0.05/500,000. We consider the proposed
equal weights for wFBAT and wT, for genome-wide significance
level 0.05 and Table 1 shows that the type-1 error rate is preserved
well. For different significance levels, we calculate in Table 2 the
empirical proportions of SNPs for which the overall family-based
association test Zi is significant at the a-levels of 0.05, 0.01, 10
23,
10
24 and 10
25. The simulation studies are conducted in the
absence and in the presence of population admixture. Table 2
does not provide any evidence for a departure of the empirical
significance levels from the theoretical levels, both in the absence
and presence of population substructure. These results confirm our
theoretical conclusions that Zi is robust against population
stratification and maintains correct type-1 error.
In the next set of simulation studies, we assess the effects of the
local population stratification on the overall family-based associ-
ation test. We generate local population stratification under the
Table 1. Empirical type-1 error for 500K GWAS at genome-
wide significance level 0.05.
FST Empirical error rate
0.00 0.0505
0.05 0.0395
0.10 0.0425
0.20 0.0450
0.30 0.0445
The number of trios, Ntrio, is assumed to be 1,000 and the empirical type-1 error
of the minimum p-value for GWAS at 500K GWAS is calculated with 2,000
replicates.
doi:10.1371/journal.pgen.1000741.t001
Table 2. Average of empirical proportion at 500K GWAS.
FST c=5 610
22 c=1 610
22 c=1 610
23 c=1 610
24 c=1 610
25
0.00 5.00610
22 9.97610
23 9.91610
24 9.86610
25 9.66610
26
0.05 5.00610
22 9.97610
23 9.91610
24 9.85610
25 9.76610
26
0.10 5.00610
22 9.96610
23 9.88610
24 9.78610
25 9.79610
26
0.20 4.99610
22 9.95610
23 9.87610
24 9.76610
25 9.60610
26
0.30 4.98610
22 9.92610
23 9.82610
24 9.68610
25 9.40610
26
The number of trios, Ntrio, is assumed to be 1,000 and the empirical proportions
of SNPs whose p-values for Zi are less than c in each replicate for 500K GWAS
are averaged over 2,000 replicates.
doi:10.1371/journal.pgen.1000741.t002
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which distinguish themselves from each other in 2 marker regions.
We assume that a subject can be from all possible 4 combinations
at the 2 particular regions, e.g. (G1, G1), (G1, G2), (G2, G1) and (G2,
G2). Both regions consist of 10K SNPs and 90K SNPs respectively
and if subjects are from the same subpopulation in each genetic
region, their assumed allele frequencies of the markers in the
corresponding region are equal. For example, the allele frequen-
cies of each marker in the marker region 1 are the same for
samples in (G1, G1) and (G1, G2), but they are different for (G1, G1)
and (G2, G2). In the simulation study, we generate the parental
genotypes based on these allele frequency assumptions and obtain
the offspring genotypes based on simulated Mendelian transmis-
sions. Using the Balding-Nichols model we considered FST’s of
0.001, 0.005, 0.01 and 0.05 in the simulation studies. The
offspring’s phenotype was generated under the null hypothesis, but
we assumed that each sub-population strata had a different
phenotypic mean: 0 for (G1, G1), 0.2 for (G1, G2), 0.4 for (G2, G1)
and 0.6 for (G2, G2). Each replicate consists of 2,000 trios with
equal number of trios for all 4 possible combinations. The data
was analyzed with the proposed overall family-based association
test and with standard linear regression after adjusting population
admixture with EIGENSTRAT [10]. For EIGENSTRAT, we
applied the principal component analysis to the mean of the
paternal and maternal genotypes at each locus because parents of
each offspring are from the same subpopulation, and then the
residuals obtained from regressing offspring genotypes and
phenotypes with eigenvectors respectively are used to calculate
the generalized Armitage trend test [27]. Table 3 provides the
empirical type-1 error for both analysis approaches based on 2,000
replicates. While EIGENSTRAT exhibits an inflated type-1 error,
the proposed overall family test maintains the theoretical
significance level.
Empirical power with simulation for 500K GWA for
quantitative trait
For the analysis of quantitative traits, Table 4 provides the
empirical power for 500K GWAS from 2000 replicates when there
is no population stratification. Under the assumption of an
additive disease model for a quantitative trait, the genetic effect, a,
is given as a function of the heritability, h
2, the minor allele
frequency pDı and the phenotypic variance, s
2, by: a=sh/
[2p(12p)(12h
2)]
0.5. In the simulation study, we assume heritabil-
ities of h
2=0.001, 0.005, 0.01 and 0.015 for 2,000, 2,500 and
3,000 trios. The allele frequency of the disease locus, pDı, is 0.3 and
the phenotypic variance is 1. We compare the achieved power
levels of the proposed overall family-based association test, Zi, with
the weighting approach by Ionita-Laza et al [12], the original
VanSteen approach [11], the QTDT approach [28] and
population-based analysis, i.e. using linear regression of the
phenotype Y on the genotype X. Bonferroni correction is used to
adjust for multiple testing in the population-based analysis, FBAT,
QTDT and the proposed method. The results in Table 4 suggest
that the proposed association test achieves power levels that
represent a major improvement over the existing methods for
family-based association tests (VanSteen [11] or Ionita-Laza [12]).
Our approach reaches the same power levels as the population-
based analysis. For the power comparisons that are shown in
Figure 1, Figure 2, and Figure 3, the number of trios is assumed to
be 1,000 in 500K GWAS and the empirical powers are calculated
based on 10,000 replicates at an a-level of 0.001 for the all genetic
Table 4. Empirical power for GWAS under no population
stratification.
Ntrio h
2 POP FBAT QTDT LIP VAN ION
2,000 0.001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
0.005 0.0200 0.0025 0.0010 0.0185 0.0080 0.0130
0.01 0.2085 0.0125 0.0180 0.1955 0.0990 0.1505
0.015 0.5725 0.0765 0.0150 0.5350 0.3045 0.4515
2,500 0.001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
0.005 0.0385 0.0030 0.0030 0.0370 0.0155 0.0210
0.01 0.3970 0.0430 0.0430 0.3760 0.2025 0.2960
0.015 0.8135 0.1420 0.1790 0.7995 0.5525 0.7380
3,000 0.001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000
0.005 0.0740 0.0020 0.0070 0.0675 0.0325 0.0495
0.01 0.5720 0.0810 0.0855 0.5495 0.3175 0.4710
0.015 0.9175 0.2665 0.3265 0.8980 0.7055 0.8630
Empirical powers are calculated from 2,000 replicates at the genome-wide
significance level 0.05 from Bonferroni method under no population
stratification. LIP stands for the proposed method using Liptak method to
combine pFBATi and pTi.VAN and ION indicate the VanSteen approach
screening top 20 SNPs and Ionita approach using an exponential weighting
scheme with partitioning parameters of K=7 and r=2 respectively. FBAT are
the results only from the within-family component and POP is the standard
population-based method.
doi:10.1371/journal.pgen.1000741.t004
Table 3. Average of empirical proportion at 100K GWAS.
Method FST c=5 610
22 c=1 610
22 c=1 610
23 c=1 610
24 c=1 610
25
EIGENSTRAT 0.001 5.07610
22 1.02610
22 1.04610
23 1.05610
24 1.02610
25
0.005 5.44610
22 1.17610
22 1.36610
23 1.72610
24 2.45610
25
0.01 5.86610
22 1.39610
22 2.09610
23 3.62610
24 7.57610
25
0.05 8.20610
22 3.24610
22 1.32610
22 6.58610
23 3.39610
23
LIP 0.001 5.00610
22 9.99610
23 9.93610
24 9.89610
25 9.70610
26
0.005 5.00610
22 9.99610
23 1.00610
23 1.01610
24 1.00610
25
0.01 5.00610
22 9.99610
23 9.97610
24 9.96610
25 9.99610
26
0.05 5.00610
22 9.98610
23 9.94610
24 9.89610
25 9.98610
26
The number of trios, Ntrio, is assumed to be 1,000. The empirical proportions of SNPs whose p-values for Zi are less than c in each replicate for 500K GWAS are averaged
over 2000 replicates when there is local population stratification. LIP stands for the proposed method using Liptak method to combine pFBATi and pTi.
doi:10.1371/journal.pgen.1000741.t003
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Ti and FBATi has similar power to the population-based method,
and the choice of equal weights performs well. The simulation
results in Table 4 also suggest that QTDT [28] approach achieves
similar power levels as the standard FBAT approach, which is
consistent with previously reported findings in the literature [29].
However, both standard FBAT and QTDT are still much less
powerful than the proposed overall family-based association test.
Table 5 shows the empirical power for a GWAS with 100,000
SNPs in the presence of population stratification. For the
parameters of this simulation study, we assume FST=0.001,
0.005, 0.01, and 0.05, and the additive mode of inheritance at the
disease locus with values for the heritability of h
2=0.005, 0.01 and
0.015. The disease allele frequency pDı in the ancestral population
is assumed to be 0.3. The phenotypic data is simulated so that
their phenotypic means for two subpopulations are 0 and 0.2
respectively. Each individual/trio is assigned to either subpopu-
lation with probability 0.5. The parental genotypes are used to
estimate the ancestry for EIGENSTRAT as before. Various
methods have been suggested to adjust the population stratifica-
tion in a population-based designs and we compare the proposed
methods with the EIGENSTRAT approach [10]. In order to
maximize the power of the proposed method, we apply the
EIGENSTRAT approach to the population-based component Ti
of our approach, i.e. principal component analysis based on the
parental genotypes and the offspring’s phenotype is integrated into
the generalized Armitage test for Ti [27]. To keep the power
comparisons unbiased, the population-based components of the
approaches by VanSteen and Ionita-Laza are also adjusted for
population admixture, using the EIGENSTRAT approach. The
results in Table 5 show that the proposed test statistic Zi is
considerably more powerful than population-based analysis
adjusted with EIGENSTRAT. QTDT is slightly more powerful
than FBAT, but it is much less powerful than LIP as is in Table 4.
This suggests that EIGENSTRAT should be applied only to
between-family component in family-based association studies.
Our unpublished work showed that the proposed approach can be
less powerful than the combination of population-based analysis
and EIGENSTRAT if pTi is calculated from the conditional mean
model [11,22] without adjusting population stratification.
Applications to a genome-wide association in the
Framingham Heart study
For the assessment of the severity of pulmonary diseases, the lung
volume of air that a subject can blow out within one second after
taking a deep breath is an important endo-phenotype. It is referred
to as the forced expiratory volume in one second (FEV1). FEV1 is
an important measure for lung function and we apply the proposed
Figure 1. Empirical power at 0.001 significance level for additive disease. POP is the empirical power of the standard population-based
method. T is the empirical power of the Wald test based on the conditional mean model [22] for between-faimly components. LIP is the empirical
power of the combined p-values with Liptak’s method. In this figure, FBAT and T are completely overlapped.
doi:10.1371/journal.pgen.1000741.g001
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applied to 550K GWAS Framingham Heart Study (FHS) data set
for FEV1, and then we confirm whether the selected SNPs are
replicated in the British 1958 Birth Cohort (BBC), another
population sample, as well as two samples of asthmatics in the the
Childhood Asthma management program (CAMP) [30] and an
Afro-Caribbean group of families from Barbados (ACG) [31]. In
FHS, 9,274 subjects were genotyped and 10,816 subjects of those
had at least one FEV1 measurement. Of the 8637 participants with
genotyping and FEV1 measures, only those with a call rate of 97%
or higher were included. We adjusted the covariates, age, sex and
the quadratic term of height that are known to be associated with
FEV1. For within-family components, the FBAT statistic for
quantitative trait was applied. Markers were excluded from the
analysisifthe numberofinformativefamilieswaslessthan20,orthe
minor allele frequency was less than 0.05. In total, 306,264 SNPs
were used for analysis and, based on the number of SNPs, rank-
based empirical p-values, pTi, and the genome-wide significance
level was obtained with Bonferroni correction. When we let n and
ninf be the total number of individuals and the number of
informative trios respectively, ninf:( 2 n2ninf) are used for the weights
of Zi because some of parental phenotypes are available.
Table 6 shows the p-values for the top 10 SNPs from the
proposed method. In our analysis, the genome-wide significance
level at 0.05 is 1.636610
27 and our results show that only the first
ranked SNP, rs805294, is significant at the genome-wide level 0.2
with Bonferroni correction. For rs805294, we also checked the
significance in other data sets, BBC, CAMP [30] and ACG [31].
In CAMP, 1215 subjects in 422 families were genotyped and there
are 488 informative trios for rs809254 and in ACG, there were
only 33 informative trios (Table 7). In the BBC, 1372 unrelated
subjects were genotyped with the Affymetrix chip and 1323
unrelated subjects genotyped with the Illumina chip. In CAMP
and ACG, age, sex and the quadratic terms of heights were
adjusted and in the BBC, age, sex, height, recent chest infection
and nurse were adjusted. Table 7 also shows that rs805294 is
significant and their directions are same for the considered studies
except for the ACG sample. In particular, in the ACG study, the
MAF of the SNP is different from other studies, which indicates a
different local LD structure; The ACG sample is from an Afro-
Caribbean population, contrary to the other studies which only
include Caucasian study subjects. In addition, the ACG sample
lacks statistical power for this particular SNP, i.e. there are only 33
informative trios in this sample. Thus, the inconsistent finding in
the ACG study could be attributable to genetic heterogeneity, i.e.
different local LD structure/flip-flop phenomena [32], or
insufficient statistical power. For meta analysis, the sample sizes
are used as weights for Liptak’s method and we use
Figure 2. Empirical power at 0.001 significance level for dominant disease. POP is the empirical power of the standard population-based
method. T is the empirical power of the Wald test based on the conditional mean model [22] for between-faimly components. LIP is the empirical
power of the combined p-values with Liptak’s method. In this figure, FBAT and T are completely overlapped.
doi:10.1371/journal.pgen.1000741.g002
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PLoS Genetics | www.plosgenetics.org 6 November 2009 | Volume 5 | Issue 11 | e1000741Figure 3. Empirical power at 0.001 significance level for recessive disease. POP is the empirical power of the standard population-based
method. T is the empirical power of the Wald test based on the conditional mean model [22] for between-family components. LIP is the empirical
power of the combined p-values with Liptak’s method. In this figure, FBAT and T are completely overlapped.
doi:10.1371/journal.pgen.1000741.g003
Table 5. Empirical power for GWAS under population stratification.
FST h
2 FBAT QTDT LIP VAN ION EIG
0.001 0.005 0.0000 0.0010 0.0083 0.0000 0.0000 0.0000
0.010 0.0000 0.0030 0.1157 0.0826 0.1157 0.0579
0.015 0.0000 0.0085 0.3884 0.2975 0.3471 0.2562
0.005 0.005 0.0000 0.0000 0.0083 0.0083 0.0083 0.0083
0.010 0.0000 0.0020 0.0909 0.0579 0.0661 0.0661
0.015 0.0083 0.0080 0.3223 0.2810 0.3140 0.1901
0.01 0.005 0.0000 0.0015 0.0000 0.0000 0.0000 0.0000
0.010 0.0000 0.0010 0.0909 0.0826 0.0579 0.0331
0.015 0.0083 0.0135 0.3636 0.2975 0.3388 0.2645
0.05 0.005 0.0000 0.0000 0.01653 0.0330 0.0248 0.0000
0.010 0.0083 0.0035 0.0992 0.0744 0.0826 0.0165
0.015 0.0165 0.0080 0.3140 0.2645 0.2727 0.2066
The number of trios, Ntrio, is assumed to be 1,000. Empirical powers are calculated from 2,000 replicates at the genome-wide significance level 0.05 from Bonferroni
method under no population stratification. LIP stands for the proposed method using Liptak method to combine pFBATi and pTi. VAN and ION indicate the VanSteen
approach selecting top 20 SNP and Ionita approach using an exponential weighting scheme with partitioning parameters of K=5 and r=2 respectively. FBAT indicates
the empirical power only from FBATi and EIG indicates the empirical power from EIGENSTRAT.
doi:10.1371/journal.pgen.1000741.t005
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tween-family information is used only for FHS. If the p-value from
Illumina gene chip in BBC and the p-values from FHS, CAMP
and ACG are combined, then the p-values by Liptak’s method
using proposed weights and Fisher’s method are 1.534610
28 and
1.081610
27 respectively, and they become 4.625610
29 and
3.554610
28 if the p-values from one-tailed tests are used for BBC,
CAMP and ACG with the same direction of FHS. If the p-value
from the Affymetrix gene chip in BBC is combined with the other
studies, then they are 3.787610
28 (Liptak’s method) and
1.890610
27 (Fisher’s method) for two-tailed tests, and
1.098610
28 (Liptak’s method) and 6.236610
28 (Fisher’s method)
for one-tailed tests. As a result we can conclude that rs805294 is
significantly associated with FEV1 at a genome-wide scale and the
gene, LY6G6C, associated with rs805293 will be investigated in
further studies.
Discussion
Genome-wide association studies have become one of the most
important tools for the identification of new disease loci in the
human genome. However, even though advances in genotyping
technology have enabled a new generation of genetic association
studies that provide robust and replicable findings, population
stratification/genetic heterogeneity and the multiple testing
problems continue to be the major issues in the statistical analysis
that have to be resolved in each study. While family-based
association tests provide analysis results that are completely
robust against confounding due to population-substructures, the
analysis approach is not optimal in terms of statistical power.
Numerous approaches have been suggested to minimize this
disadvantage of family-based association tests but the previous
approaches had to compromise either in terms of robustness or in
terms of efficiency.
In this communication, we develop an approach that efficiently
utilizes all available data, while maintaining complete robustness
against confounding due to population substructure. The proposed
methods combines the p-values of the family-based tests (the
within-component) with the rank-based p-values for population-
based analysis (the between component) to achieve optimal power
levels. The use of rank-based p-values for the population-based
component is similar in spirit to the genomic control approach. In
principle, the genomic control functions as rescaling the variance
inflated due to population stratification under the assumption of
the constant FST. Rank-based p-value directly rescales the statistics
based on their ranks, which always generates the uniformly
distributed p-value and provides validity even for varying FST due
to local population stratification etc.
Although our simulations are limited to independent unascer-
tained samples and quantitative traits, the proposed work can be
easily extended to ascertained samples, large pedigree, or different
trait types, etc. By replacing the parental genotypes with the
sufficient statistics by Rabinowitz&Laird [19], the FBAT-statistic
and the screening-statistic can be adopted straight-forwardly to
designs with extended pedigrees [23]. Similarly, parental pheno-
types can be incorporated into the conditional mean model [23] or
its non-parametric extensions [33] as additional outcome vari-
ables. The optimal weights can vary between the different
Table 6. Applications to forced expiratory volume in one second in Framingham Heart study.
SNP Chrom Position MAF Num. Info. Fam. FBATi pTi Zi
rs805294 6 31796196 0.340 918 4.300610
23 2.073610
25 5.929610
27
rs10863838 1 208750806 0.450 1016 7.408610
25 2.535610
23 2.553610
26
rs6794842 3 119308208 0.331 950 3.226610
22 2.400610
25 6.654610
26
rs804963 14 85918211 0.460 1031 9.786610
22 2.775610
26 7.060610
26
rs525914 11 119200660 0.187 711 9.204610
24 1.888610
23 2.081610
25
rs1886280 10 89347496 0.362 971 1.797610
22 2.297610
24 2.511610
25
rs710469 3 188467212 0.491 1058 3.202610
23 1.388610
23 2.639610
25
rs10799746 1 22497833 0.168 651 1.388610
22 3.538610
24 2.748610
25
rs1225888 20 15972225 0.449 1007 7.518610
25 1.736610
22 2.994610
25
rs4638547 15 71122046 0.377 999 3.454610
25 2.760610
22 3.549610
25
The number of markers is 306,264 and the genome-wide significance level at 0.05 is 1.636 610
27. The top 10 SNPs from Zi are selected, assuming additive disease
mode of inheritance. For pTi, the estimated powers are used and the weights for LIP are calculated with the number of informative trios.
doi:10.1371/journal.pgen.1000741.t006
Table 7. Descriptive statistics and results of rs805294 in different studies.
FHS British Cohort CAMP BAR
Affy Illumina
Num. Info. Fam. 918 - - 488 33
Sample Size - 1372 1323 - -
MAF 0.34 0.36 0.36 0.33 0.22
P-values 25.929610
27 21.234610
22 26.534610
23 21.370610
22 7.84610
21
The negative sign of the P-values indicates that the minor alleles are under-expressed in cases.
doi:10.1371/journal.pgen.1000741.t007
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but limited initial simulation studies suggest that equal weights,
while not always the most powerful choice in such situation, will
always result in more powerful analysis than currently used
methods.
Supporting Information
Text S1 The validity of the proposed method.
Found at: doi:10.1371/journal.pgen.1000741.s001 (0.04 MB
DOC)
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